Contemporary Area‐Level Mortgage Loan Denial Risk and Health‐Related Quality of Life Among Cancer Survivors
Cancer Medicine · 2025
DOI: 10.1002/cam4.71433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Jordyn A Brown und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Quality of Life, Cancer Survivors, Neoplasms. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Background
Historical and contemporary mortgage lending practices have been associated with worse cancer outcomes. We estimated the association between mortgage loan denial risk and health‐related quality of life (HRQoL) among survivors at a large tertiary medical center in North Carolina (NC).
Methods
Mortgage denial risk, calculated using Home Mortgage Disclosure Act data (2010–2014), was linked by census tract to UNC Cancer Survivorship Cohort survivors who resided within NC metropolitan statistical areas (MSAs). HRQoL was measured using the validated Functional Assessment of Cancer Therapy‐General (FACT‐G). Differences in well‐being across seven MSAs were assessed using Pearson chi‐square tests and modified Poisson regression models adjusted for demographic and socioeconomic characteristics.
Results
Over 40% of survivors reported low overall well‐being, while more than one‐third of survivors reported low physical, social, emotional, or functional well‐being. FACT‐G scores were 6.2 (95% CI: 1.5, 10.9) points lower among Greensboro survivors; 4.1 (95% CI: 0.1, 8.1) points lower among Fayetteville MSA survivors; and 9.6 (95% CI: 2.5, 16.8) points lower among Charlotte survivors at a higher risk for mortgage loan denial compared to those at lower risk. Racial differences in FACT‐G scores were only observed among Greensboro and Charlotte MSA survivors, whereas sex differences were limited to Charlotte survivors.
Conclusions
Mortgage loan denial was associated with worse overall HRQoL in Greensboro, Fayetteville, and Charlotte, but not in other NC MSAs. Further investigation into the role of place in other NC MSAs is needed to identify opportunities to support survivors across the cancer control continuum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
- Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
- Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
- Carolina Population Center, University of North Carolina, Chapel Hill, North Carolina, USA.
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
ORCID-Profile: Jordyn A Brown, Hazel B Nichols
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Brown, J. A., Ellington, T. D., Moubadder, L., Bliss, M., Kumar, A. D., Martin, C. L., Farnan, L., Gerstel, A., McCullough, L. E., & Nichols, H. B. (2025). Contemporary Area‐Level Mortgage Loan Denial Risk and Health‐Related Quality of Life Among Cancer Survivors. Cancer Medicine. https://doi.org/10.1002/cam4.71433
Vancouver
Brown JA, Ellington TD, Moubadder L, Bliss M, Kumar AD, Martin CL, et al. Contemporary Area‐Level Mortgage Loan Denial Risk and Health‐Related Quality of Life Among Cancer Survivors. Cancer Medicine. 2025. doi:10.1002/cam4.71433
BibTeX
@article{Brown2025,
author = {Brown, Jordyn A and Ellington, Taylor D and Moubadder, Leah and Bliss, Maya and Kumar, Anjali D and Martin, Chantel L and Farnan, Laura and Gerstel, Adrian and McCullough, Lauren E and Nichols, Hazel B},
title = {Contemporary Area‐Level Mortgage Loan Denial Risk and Health‐Related Quality of Life Among Cancer Survivors},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.71433}
}
EUVIMED